TETRAPHASE PHARMACEUTICALS INC: cashflow_financing

Value{"amount": 93146000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"}
Period2017-01-01 – 2017-12-31
Statuscurrent
EntityTETRAPHASE PHARMACEUTICALS INC
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001564590-19-008034 · Open the official SEC filing →
Retrieved: 2026-08-19T13:11:20.304535+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001373707/cashflow-financing/2017-12-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/a1df8196-4588-496b-bd50-39fa847cd1d5

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies